Company news

Vanda Pharmaceuticals Inc. news in 2022

Vanda Pharmaceuticals Inc.'s news releases, calls and decks from 2022, newest first.

View company

Fanapt® Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study

December 18, 2022

Vanda Pharmaceuticals Provides an Update to HETLIOZ® ANDA Litigation Appeal: Federal Circuit grants motion to temporarily enjoin generic launch

December 15, 2022

Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation

December 12, 2022

Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study of VQW-765 in the Treatment of Acute Performance Anxiety

December 1, 2022

Vanda Pharmaceuticals Announces Participation at November 2022 Investor Conferences

November 7, 2022

Vanda Pharmaceuticals Reports Third Quarter 2022 Financial Results

November 1, 2022

Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022

October 25, 2022

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of Cholera

October 20, 2022

Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics

September 28, 2022

Vanda Pharmaceuticals announces notice of opportunity for an FDA hearing on the sNDA for HETLIOZ® in jet lag disorder

September 6, 2022

Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results

August 2, 2022

Vanda Pharmaceuticals to Announce Second Quarter 2022 Financial Results on August 3, 2022

July 26, 2022

Vanda Pharmaceuticals Announces Participation in the Jefferies 2022 Global Healthcare Conference

June 1, 2022

Vanda Pharmaceuticals Announces Presentations at SLEEP 2022

May 30, 2022

Vanda Pharmaceuticals Announces Presentations at DDW 2022

May 18, 2022

Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results

May 4, 2022

Vanda Pharmaceuticals Announces Participation in the BofA Securities 2022 Healthcare Conference

May 3, 2022

Vanda Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 5, 2022

April 27, 2022

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

February 22, 2022

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

February 16, 2022

Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis

February 3, 2022

Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN

January 13, 2022

Calls in 2022

Decks in 2022